2024-04-012025-03-312025-03-31false09221436EALING GP LIMITED2025-08-04falseiso4217:GBPxbrli:pure092214362024-03-31092214362025-03-31092214362024-04-012025-03-31092214362023-03-31092214362024-03-31092214362023-04-012024-03-3109221436bus:SmallEntities2024-04-012025-03-3109221436bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3109221436bus:AbridgedAccounts2024-04-012025-03-3109221436bus:PrivateLimitedCompanyLtd2024-04-012025-03-3109221436core:WithinOneYear2025-03-3109221436core:AfterOneYear2025-03-3109221436core:WithinOneYear2024-03-3109221436core:AfterOneYear2024-03-3109221436core:ShareCapital2025-03-3109221436core:SharePremium2025-03-3109221436core:RevaluationReserve2025-03-3109221436core:OtherReservesSubtotal2025-03-3109221436core:RetainedEarningsAccumulatedLosses2025-03-3109221436core:ShareCapital2024-03-3109221436core:SharePremium2024-03-3109221436core:RevaluationReserve2024-03-3109221436core:OtherReservesSubtotal2024-03-3109221436core:RetainedEarningsAccumulatedLosses2024-03-3109221436core:LandBuildings2025-03-3109221436core:PlantMachinery2025-03-3109221436core:Vehicles2025-03-3109221436core:FurnitureFittings2025-03-3109221436core:OfficeEquipment2025-03-3109221436core:NetGoodwill2025-03-3109221436core:IntangibleAssetsOtherThanGoodwill2025-03-3109221436core:ListedExchangeTraded2025-03-3109221436core:UnlistedNon-exchangeTraded2025-03-3109221436core:LandBuildings2024-03-3109221436core:PlantMachinery2024-03-3109221436core:Vehicles2024-03-3109221436core:FurnitureFittings2024-03-3109221436core:OfficeEquipment2024-03-3109221436core:NetGoodwill2024-03-3109221436core:IntangibleAssetsOtherThanGoodwill2024-03-3109221436core:ListedExchangeTraded2024-03-3109221436core:UnlistedNon-exchangeTraded2024-03-3109221436core:LandBuildings2024-04-012025-03-3109221436core:PlantMachinery2024-04-012025-03-3109221436core:Vehicles2024-04-012025-03-3109221436core:FurnitureFittings2024-04-012025-03-3109221436core:OfficeEquipment2024-04-012025-03-3109221436core:NetGoodwill2024-04-012025-03-3109221436core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109221436core:ListedExchangeTraded2024-04-012025-03-3109221436core:UnlistedNon-exchangeTraded2024-04-012025-03-3109221436core:MoreThanFiveYears2024-04-012025-03-3109221436core:Non-currentFinancialInstruments2025-03-3109221436core:Non-currentFinancialInstruments2024-03-3109221436dpl:CostSales2024-04-012025-03-3109221436dpl:DistributionCosts2024-04-012025-03-3109221436core:LandBuildings2024-04-012025-03-3109221436core:PlantMachinery2024-04-012025-03-3109221436core:Vehicles2024-04-012025-03-3109221436core:FurnitureFittings2024-04-012025-03-3109221436core:OfficeEquipment2024-04-012025-03-3109221436dpl:AdministrativeExpenses2024-04-012025-03-3109221436core:NetGoodwill2024-04-012025-03-3109221436core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3109221436dpl:GroupUndertakings2024-04-012025-03-3109221436dpl:ParticipatingInterests2024-04-012025-03-3109221436dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3109221436core:ListedExchangeTraded2024-04-012025-03-3109221436dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3109221436core:UnlistedNon-exchangeTraded2024-04-012025-03-3109221436dpl:CostSales2023-04-012024-03-3109221436dpl:DistributionCosts2023-04-012024-03-3109221436core:LandBuildings2023-04-012024-03-3109221436core:PlantMachinery2023-04-012024-03-3109221436core:Vehicles2023-04-012024-03-3109221436core:FurnitureFittings2023-04-012024-03-3109221436core:OfficeEquipment2023-04-012024-03-3109221436dpl:AdministrativeExpenses2023-04-012024-03-3109221436core:NetGoodwill2023-04-012024-03-3109221436core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3109221436dpl:GroupUndertakings2023-04-012024-03-3109221436dpl:ParticipatingInterests2023-04-012024-03-3109221436dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3109221436core:ListedExchangeTraded2023-04-012024-03-3109221436dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3109221436core:UnlistedNon-exchangeTraded2023-04-012024-03-3109221436core:NetGoodwill2025-03-3109221436core:IntangibleAssetsOtherThanGoodwill2025-03-3109221436core:LandBuildings2025-03-3109221436core:PlantMachinery2025-03-3109221436core:Vehicles2025-03-3109221436core:FurnitureFittings2025-03-3109221436core:OfficeEquipment2025-03-3109221436core:AfterOneYear2025-03-3109221436core:WithinOneYear2025-03-3109221436core:ListedExchangeTraded2025-03-3109221436core:UnlistedNon-exchangeTraded2025-03-3109221436core:ShareCapital2025-03-3109221436core:SharePremium2025-03-3109221436core:RevaluationReserve2025-03-3109221436core:OtherReservesSubtotal2025-03-3109221436core:RetainedEarningsAccumulatedLosses2025-03-3109221436core:NetGoodwill2024-03-3109221436core:IntangibleAssetsOtherThanGoodwill2024-03-3109221436core:LandBuildings2024-03-3109221436core:PlantMachinery2024-03-3109221436core:Vehicles2024-03-3109221436core:FurnitureFittings2024-03-3109221436core:OfficeEquipment2024-03-3109221436core:AfterOneYear2024-03-3109221436core:WithinOneYear2024-03-3109221436core:ListedExchangeTraded2024-03-3109221436core:UnlistedNon-exchangeTraded2024-03-3109221436core:ShareCapital2024-03-3109221436core:SharePremium2024-03-3109221436core:RevaluationReserve2024-03-3109221436core:OtherReservesSubtotal2024-03-3109221436core:RetainedEarningsAccumulatedLosses2024-03-3109221436core:NetGoodwill2023-03-3109221436core:IntangibleAssetsOtherThanGoodwill2023-03-3109221436core:LandBuildings2023-03-3109221436core:PlantMachinery2023-03-3109221436core:Vehicles2023-03-3109221436core:FurnitureFittings2023-03-3109221436core:OfficeEquipment2023-03-3109221436core:AfterOneYear2023-03-3109221436core:WithinOneYear2023-03-3109221436core:ListedExchangeTraded2023-03-3109221436core:UnlistedNon-exchangeTraded2023-03-3109221436core:ShareCapital2023-03-3109221436core:SharePremium2023-03-3109221436core:RevaluationReserve2023-03-3109221436core:OtherReservesSubtotal2023-03-3109221436core:RetainedEarningsAccumulatedLosses2023-03-3109221436core:AfterOneYear2024-04-012025-03-3109221436core:WithinOneYear2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3109221436core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3109221436core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3109221436core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3109221436core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3109221436core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3109221436bus:Director12024-04-012025-03-3109221436bus:Director22024-04-012025-03-3109221436bus:Director32024-04-012025-03-3109221436bus:Director42024-04-012025-03-3109221436bus:Director52024-04-012025-03-3109221436bus:Director62024-04-012025-03-31

EALING GP LIMITED

Registered Number
09221436
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

EALING GP LIMITED
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

BELTON, Julie Anne
COOPER, Anne
DATTA, Sidhartha Sankar Jonathan, Dr
FERNANDEZ, Eva Maria Clemente, Dr
MIKHAIL, Mena Mark, Dr
SHERGILL, Sukhpal Singh, Dr

Registered Address

Ramsay Brown Llp The Brentano Suite
Solar House, 915 High Road
North Finchley
N12 8QJ

Registered Number

09221436 (England and Wales)
EALING GP LIMITED
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets31,8041,886
1,8041,886
Current assets
Debtors4493,646689,083
Cash at bank and on hand681,751513,173
1,175,3971,202,256
Creditors amounts falling due within one year5(934,900)(979,646)
Net current assets (liabilities)240,497222,610
Total assets less current liabilities242,301224,496
Net assets242,301224,496
Capital and reserves
Called up share capital165165
Profit and loss account242,136224,331
Shareholders' funds242,301224,496
The financial statements were approved and authorised for issue by the Board of Directors on 4 August 2025, and are signed on its behalf by:
SHERGILL, Sukhpal Singh, Dr
Director
Registered Company No. 09221436
EALING GP LIMITED
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. The company recognises revenue when the amount of revenue can be measured reliably, when it is probable that future economic benefits will flow to the entity and when specific criteria have been met as described below.
Revenue from sale of goods
Sales of goods are recognised when the company has delivered the goods to the customer, no other significant obligation remains unfulfilled that may affect the customer's acceptance of the products and risks and rewards of ownership have transferred to them.
Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year together with an associated expense in profit or loss. The liabilities are classified as current obligations in the statement of financial position because they are expected to be settled wholly within twelve months after the end of the period.
Current taxation
Taxation Taxation expense represents the aggregate amount of current tax and deferred tax recognised in the reporting period. Current Tax The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit before tax as reported in the income statement because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Tangible fixed assets and depreciation
Property, plant and equipment is stated at cost less accumulated depreciation and impairment losses. Part of an item of property, plant and equipment having different useful lives are accounted for as separate items. Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight-­line method. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis. Depreciation is provided to write off the cost less estimated residual value, of each asset over its expected useful life as follows:

Reducing balance (%)Straight line (years)
Fixtures and fittings15-
Office Equipment-25
2.Average number of employees

20252024
Average number of employees during the year6466
3.Tangible fixed assets

Total

£
Cost or valuation
At 01 April 245,990
Additions1,116
At 31 March 257,106
Depreciation and impairment
At 01 April 244,104
Charge for year1,198
At 31 March 255,302
Net book value
At 31 March 251,804
At 31 March 241,886
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables342,131318,858
Other debtors3,53295,293
Prepayments and accrued income147,983274,932
Total493,646689,083
5.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables12,79137,187
Taxation and social security76,37671,415
Other creditors15,5545,128
Accrued liabilities and deferred income830,179865,916
Total934,900979,646
6.Related party transactions
During the year, the company paid £43,400 (2024: £68,655) to the respective surgeries where the directors of the company are partners.